NCT00504439 - A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 4, 2007

Primary Completion Date

September 6, 2007

Study Completion Date

September 6, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

SB-656933-AAA

The doses of SB-656933 (20 mg, 50 mg or 100 mg) will be provided as a combination of 10 mg and 50 mg tablets of SB-656933-AAA. The tablets will be administered orally.

DRUG

Matching placebo

SB-656933-AAA matching placebo tablets will be administered orally.

DRUG

Simvastatin

Simvastatin will be provided as a 40 mg tablet.

Trial Locations (1)

NW10 7NS

GSK Investigational Site, London